Press Releases
View all of the American Hospital Association (AHA) press releases for the media on health care issues impacting hospitals and health systems.
The American Hospital Association has elected six new members to its Board of Trustees for three-year terms beginning Jan. 1, 2022. The Board of Trustees is the highest policymaking body of the AHA and has ultimate authority for the governance and management of its directions and finances.
AHA statement on FY 2022 final IPPS rule from Executive Vice President Stacey Hughes.
The American Hospital Association (AHA) Board of Trustees has elected John Haupert, president and CEO of Grady Health System in Atlanta, as its Chair-elect Designate.
The health, safety and well-being of health care personnel – and the patients and communities they serve – is the highest priority for America’s hospitals and health systems.
The American Hospital Association announced that Yale New Haven Health, headquartered in New Haven, Conn., has been named the 2021 recipient of the American Hospital Association’s Quest for Quality Prize. Yuma Regional Medical Center, based in Yuma, Ariz., and Memorial Healthcare System,…
The American Hospital Association (AHA) Board of Trustees today adopted a policy statement on the vaccination of health care workers. The statement supports hospitals and health systems that adopt mandatory COVID-19 vaccination policies, with local factors and circumstances shaping whether and how…
Together, the American Hospital Association (AHA), American Medical Association (AMA) and American Nurses Association (ANA) released a public service announcement (PSA) featuring their leaders urging the American public to ask questions, follow the science and get vaccinated. The PSA stresses that…
AHA statement on 2022 OPPS proposed rule from Executive Vice President Stacey Hughes.
AHA statement on executive order on competition from AHA President and CEO Rick Pollack.
We are pleased that the U.S. Supreme Court has agreed to hear the compelling arguments in our case on payments cuts to the 340B drug pricing program that are adversely impacting care to patients.